查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1591892

人体生长荷尔蒙市场：按给药途径、类型、分布和应用划分 - 2025-2030 年全球预测

Human Growth Hormone Market by Route of Administration (Intramuscular, Intravenous, Oral), Type (Amino Acid Derivatives, Peptide Hormones, Steroid Hormones), Distribution, Application - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 192 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年人体生长荷尔蒙市场价值为57.7亿美元，预计2024年将达到62.8亿美元，复合年增长率为8.87%，到2030年将达到104.6亿美元。

人体生长荷尔蒙(HGH) 是医疗和治疗应用的重要成分，涉及多种市场，包括治疗应用、抗衰老治疗、健身和性能增强。将其纳入针对儿童和成人生长激素缺乏症、透纳氏症、普瑞德-威利症候群和慢性肾臟病的应对措施中，强调了其在医疗保健中的需求。它的用途通常延伸到美容和运动领域，用于肌肉生长和修復。最终使用范围主要是医院、诊所和健身中心。市场成长主要受到医疗保健意识提高、重组 DNA 技术进步、慢性病盛行率增加以及美容和运动领域采用率上升的影响。关键的商机在于将穿戴式技术整合到个人化医疗和健康追踪中，以回应日益增长的健康意识。然而，这个市场面临着高昂的治疗成本、严格的法律规范、潜在的副作用以及围绕非治疗用途的伦理问题的限制。在运动中滥用 HGH 和不受监管的分销管道是主要挑战。

主要市场统计
基准年[2023] 57.7亿美元
预计年份 [2024] 62.8亿美元
预测年份 [2030] 104.6亿美元
复合年增长率（%） 8.87%

对于市场相关人员来说，生物相似药激素的开拓可以促进创新、降低成本并提高可及性。专注于优化剂量和给药方法（例如缓释性）的研究具有广泛的成长潜力。此外，利用人工智慧提供针对患者的解决方案并扩大其在与老龄化相关的治疗中的应用可能会推动市场扩张。该市场本质上是动态的，受到医疗保健进步的推动，但受到监管环境的阻碍。这一领域的成功需要与国际医疗标准保持一致，并积极参与治疗用途的道德游说。因此，持续投资研发以及与医疗保健提供者建立策略伙伴关係对于克服限制并抓住新机会至关重要。

市场动态：揭示快速发展的人体生长荷尔蒙市场的关键市场洞察

供需的动态交互作用正在改变人体生长荷尔蒙市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 与荷尔蒙失调相关的病例迅速增加
    • 增加报销政策
    • 生长激素缺乏症增加
  • 市场限制因素
    • 人体生长荷尔蒙治疗的高成本
  • 市场机会
    • 市面上人体生长荷尔蒙产品数量增加
    • 私营和公共部门的研发资金迅速增加
  • 市场挑战
    • 人体生长荷尔蒙疗法对人体的不良影响

波特五力：驾驭人体生长荷尔蒙市场的策略工具

波特的五力框架是了解人体生长荷尔蒙市场竞争格局的关键工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解外部对人体生长荷尔蒙市场的影响

外部宏观环境因素在塑造人体生长荷尔蒙市场的表现动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解人体生长荷尔蒙市场的竞争状况

人体生长荷尔蒙市场的详细市场占有率分析可以对供应商的绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的见解，以应对日益激烈的竞争。

FPNV 定位矩阵人体生长荷尔蒙市场供应商的绩效评估

FPNV 定位矩阵是评估人体生长荷尔蒙市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议绘製人体生长荷尔蒙市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，对人体生长荷尔蒙市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机，并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：对当前市场环境的详细审查、主要企业的广泛资料、对其在市场中的影响力和整体影响力的评估。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 与荷尔蒙失调相关的病例迅速增加
      • 扩大赎回政策
      • 生长激素缺乏症增加
    • 抑制因素
      • 与人体生长荷尔蒙治疗程序相关的费用很高
    • 机会
      • 人体生长荷尔蒙产品上市数量增加
      • 私营和公共部门的研发资金迅速增加
    • 任务
      • 人体生长荷尔蒙疗法对人体的不良影响
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章人体生长荷尔蒙市场：依给药途径

  • 肌肉注射
  • 静脉
  • 口服
  • 皮下的

第七章人体生长荷尔蒙市场：依类型

  • 胺基酸衍生物
  • 肽激素
  • 类固醇激素

第八章人体生长荷尔蒙市场经销商

  • 医院药房
  • 网路药房
  • 零售药房

第九章人体生长荷尔蒙市场：依应用

  • 生长激素缺乏症
  • 普瑞德威利症候群
  • 透纳氏症

第十章美洲人体生长荷尔蒙市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十一章亚太地区人体生长荷尔蒙市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十二章欧洲、中东和非洲人体生长荷尔蒙市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十三章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • Aeterna Zentaris, inc.
  • Anhui Anke Biotechnology Co., Ltd
  • Biopartners GmbH
  • Eli Lilly and Company
  • Ferring BV
  • GeneScience Pharmaceuticals Co., Ltd
  • Ipsen SA
  • Merck KGaA
  • Novartis AG
  • Novo Nordisk A/S
  • Pfizer Inc.
  • Roche Holdings, Inc.
  • Sandoz International GmbH
  • Teva Pharmaceutical Industries Limited
Product Code: MRR-43127F7278D3

The Human Growth Hormone Market was valued at USD 5.77 billion in 2023, expected to reach USD 6.28 billion in 2024, and is projected to grow at a CAGR of 8.87%, to USD 10.46 billion by 2030.

Human Growth Hormone (HGH), a critical component in medical and therapeutic applications, spans a diverse market encompassing therapeutic uses, anti-aging treatments, fitness, and performance enhancement. Its inclusion in addressing growth hormone deficiency in children and adults, Turner syndrome, Prader-Willi syndrome, and chronic kidney disease underscores its necessity in healthcare. The application often extends to aesthetics and athletic realms, where it is utilized for muscle growth and repair. The end-use scope predominantly covers hospitals, clinics, and fitness centers. Market growth is chiefly influenced by rising healthcare awareness, advancements in recombinant DNA technologies, increased prevalence of chronic ailments, and heightened adoption in aesthetic and athletic sectors. Key opportunities lie in personalized medicine and the integration of wearable technology for health tracking, catering to an increasingly health-conscious population. Nonetheless, this market faces limitations due to high treatment costs, stringent regulatory frameworks, potential side effects, and ethical concerns surrounding non-therapeutic use. The misuse of HGH in sports and unregulated distribution channels poses significant challenges.

KEY MARKET STATISTICS
Base Year [2023] USD 5.77 billion
Estimated Year [2024] USD 6.28 billion
Forecast Year [2030] USD 10.46 billion
CAGR (%) 8.87%

For market players, innovation can thrive through the development of biosimilar hormones, potentially reducing costs and increasing accessibility. Research focusing on optimizing dosage and administration methods, such as sustained-release formulations, holds promising growth potential. Additionally, leveraging AI for patient-specific solutions and expanding applications for age-related treatment can propel market expansion. The market reveals a dynamic nature, driven by healthcare advancements but hindered by regulatory landscapes. Successful navigation in this domain requires harmonization with international health standards and proactive participation in ethical lobbying for therapeutic-focused use. As such, continued investment in R&D and strategic partnerships with healthcare providers are critical to overcoming limitations and seizing emerging opportunities.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Human Growth Hormone Market

The Human Growth Hormone Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Surge in the cases related to the hormonal disorders
    • Increase in the reimbursement policies
    • Growing growth hormone deficiency disorders
  • Market Restraints
    • Cost related to human growth hormone therapies procedures is high
  • Market Opportunities
    • Growing number of product launches of the human growth hormone
    • Surge in research and development fundings from the private as well as public sector
  • Market Challenges
    • Adverse impact of human growth hormone therapies on human bodies

Porter's Five Forces: A Strategic Tool for Navigating the Human Growth Hormone Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Human Growth Hormone Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Human Growth Hormone Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Human Growth Hormone Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Human Growth Hormone Market

A detailed market share analysis in the Human Growth Hormone Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Human Growth Hormone Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Human Growth Hormone Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Human Growth Hormone Market

A strategic analysis of the Human Growth Hormone Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Human Growth Hormone Market, highlighting leading vendors and their innovative profiles. These include Aeterna Zentaris, inc., Anhui Anke Biotechnology Co., Ltd, Biopartners GmbH, Eli Lilly and Company, Ferring B.V., GeneScience Pharmaceuticals Co., Ltd, Ipsen S.A, Merck KGaA, Novartis AG, Novo Nordisk A/S, Pfizer Inc., Roche Holdings, Inc., Sandoz International GmbH, and Teva Pharmaceutical Industries Limited.

Market Segmentation & Coverage

This research report categorizes the Human Growth Hormone Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Route of Administration, market is studied across Intramuscular, Intravenous, Oral, and Subcutaneous.
  • Based on Type, market is studied across Amino Acid Derivatives, Peptide Hormones, and Steroid Hormones.
  • Based on Distribution, market is studied across Hospital Pharmacy, Online Pharmacy, and Retail Pharmacy.
  • Based on Application, market is studied across Growth Hormone Deficiency, Prader-Willi Syndrome, and Turner Syndrome.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Surge in the cases related to the hormonal disorders
      • 5.1.1.2. Increase in the reimbursement policies
      • 5.1.1.3. Growing growth hormone deficiency disorders
    • 5.1.2. Restraints
      • 5.1.2.1. Cost related to human growth hormone therapies procedures is high
    • 5.1.3. Opportunities
      • 5.1.3.1. Growing number of product launches of the human growth hormone
      • 5.1.3.2. Surge in research and development fundings from the private as well as public sector
    • 5.1.4. Challenges
      • 5.1.4.1. Adverse impact of human growth hormone therapies on human bodies
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Human Growth Hormone Market, by Route of Administration

  • 6.1. Introduction
  • 6.2. Intramuscular
  • 6.3. Intravenous
  • 6.4. Oral
  • 6.5. Subcutaneous

7. Human Growth Hormone Market, by Type

  • 7.1. Introduction
  • 7.2. Amino Acid Derivatives
  • 7.3. Peptide Hormones
  • 7.4. Steroid Hormones

8. Human Growth Hormone Market, by Distribution

  • 8.1. Introduction
  • 8.2. Hospital Pharmacy
  • 8.3. Online Pharmacy
  • 8.4. Retail Pharmacy

9. Human Growth Hormone Market, by Application

  • 9.1. Introduction
  • 9.2. Growth Hormone Deficiency
  • 9.3. Prader-Willi Syndrome
  • 9.4. Turner Syndrome

10. Americas Human Growth Hormone Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Human Growth Hormone Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Human Growth Hormone Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Aeterna Zentaris, inc.
  • 2. Anhui Anke Biotechnology Co., Ltd
  • 3. Biopartners GmbH
  • 4. Eli Lilly and Company
  • 5. Ferring B.V.
  • 6. GeneScience Pharmaceuticals Co., Ltd
  • 7. Ipsen S.A
  • 8. Merck KGaA
  • 9. Novartis AG
  • 10. Novo Nordisk A/S
  • 11. Pfizer Inc.
  • 12. Roche Holdings, Inc.
  • 13. Sandoz International GmbH
  • 14. Teva Pharmaceutical Industries Limited

LIST OF FIGURES

  • FIGURE 1. HUMAN GROWTH HORMONE MARKET RESEARCH PROCESS
  • FIGURE 2. HUMAN GROWTH HORMONE MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL HUMAN GROWTH HORMONE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL HUMAN GROWTH HORMONE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL HUMAN GROWTH HORMONE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL HUMAN GROWTH HORMONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL HUMAN GROWTH HORMONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL HUMAN GROWTH HORMONE MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL HUMAN GROWTH HORMONE MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL HUMAN GROWTH HORMONE MARKET SIZE, BY DISTRIBUTION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL HUMAN GROWTH HORMONE MARKET SIZE, BY DISTRIBUTION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL HUMAN GROWTH HORMONE MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL HUMAN GROWTH HORMONE MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS HUMAN GROWTH HORMONE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS HUMAN GROWTH HORMONE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES HUMAN GROWTH HORMONE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES HUMAN GROWTH HORMONE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC HUMAN GROWTH HORMONE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC HUMAN GROWTH HORMONE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA HUMAN GROWTH HORMONE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA HUMAN GROWTH HORMONE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. HUMAN GROWTH HORMONE MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. HUMAN GROWTH HORMONE MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. HUMAN GROWTH HORMONE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL HUMAN GROWTH HORMONE MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL HUMAN GROWTH HORMONE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL HUMAN GROWTH HORMONE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. HUMAN GROWTH HORMONE MARKET DYNAMICS
  • TABLE 7. GLOBAL HUMAN GROWTH HORMONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL HUMAN GROWTH HORMONE MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL HUMAN GROWTH HORMONE MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL HUMAN GROWTH HORMONE MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL HUMAN GROWTH HORMONE MARKET SIZE, BY SUBCUTANEOUS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL HUMAN GROWTH HORMONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL HUMAN GROWTH HORMONE MARKET SIZE, BY AMINO ACID DERIVATIVES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL HUMAN GROWTH HORMONE MARKET SIZE, BY PEPTIDE HORMONES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL HUMAN GROWTH HORMONE MARKET SIZE, BY STEROID HORMONES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL HUMAN GROWTH HORMONE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL HUMAN GROWTH HORMONE MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL HUMAN GROWTH HORMONE MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL HUMAN GROWTH HORMONE MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL HUMAN GROWTH HORMONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL HUMAN GROWTH HORMONE MARKET SIZE, BY GROWTH HORMONE DEFICIENCY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL HUMAN GROWTH HORMONE MARKET SIZE, BY PRADER-WILLI SYNDROME, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL HUMAN GROWTH HORMONE MARKET SIZE, BY TURNER SYNDROME, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS HUMAN GROWTH HORMONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS HUMAN GROWTH HORMONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS HUMAN GROWTH HORMONE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS HUMAN GROWTH HORMONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS HUMAN GROWTH HORMONE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA HUMAN GROWTH HORMONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA HUMAN GROWTH HORMONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 31. ARGENTINA HUMAN GROWTH HORMONE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 32. ARGENTINA HUMAN GROWTH HORMONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 33. BRAZIL HUMAN GROWTH HORMONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 34. BRAZIL HUMAN GROWTH HORMONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. BRAZIL HUMAN GROWTH HORMONE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 36. BRAZIL HUMAN GROWTH HORMONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 37. CANADA HUMAN GROWTH HORMONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 38. CANADA HUMAN GROWTH HORMONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. CANADA HUMAN GROWTH HORMONE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 40. CANADA HUMAN GROWTH HORMONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 41. MEXICO HUMAN GROWTH HORMONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 42. MEXICO HUMAN GROWTH HORMONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. MEXICO HUMAN GROWTH HORMONE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 44. MEXICO HUMAN GROWTH HORMONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 45. UNITED STATES HUMAN GROWTH HORMONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 46. UNITED STATES HUMAN GROWTH HORMONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. UNITED STATES HUMAN GROWTH HORMONE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 48. UNITED STATES HUMAN GROWTH HORMONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 49. UNITED STATES HUMAN GROWTH HORMONE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 50. ASIA-PACIFIC HUMAN GROWTH HORMONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 51. ASIA-PACIFIC HUMAN GROWTH HORMONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. ASIA-PACIFIC HUMAN GROWTH HORMONE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 53. ASIA-PACIFIC HUMAN GROWTH HORMONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 54. ASIA-PACIFIC HUMAN GROWTH HORMONE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 55. AUSTRALIA HUMAN GROWTH HORMONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 56. AUSTRALIA HUMAN GROWTH HORMONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. AUSTRALIA HUMAN GROWTH HORMONE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 58. AUSTRALIA HUMAN GROWTH HORMONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 59. CHINA HUMAN GROWTH HORMONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 60. CHINA HUMAN GROWTH HORMONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. CHINA HUMAN GROWTH HORMONE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 62. CHINA HUMAN GROWTH HORMONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 63. INDIA HUMAN GROWTH HORMONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 64. INDIA HUMAN GROWTH HORMONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. INDIA HUMAN GROWTH HORMONE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 66. INDIA HUMAN GROWTH HORMONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 67. INDONESIA HUMAN GROWTH HORMONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 68. INDONESIA HUMAN GROWTH HORMONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. INDONESIA HUMAN GROWTH HORMONE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 70. INDONESIA HUMAN GROWTH HORMONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 71. JAPAN HUMAN GROWTH HORMONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 72. JAPAN HUMAN GROWTH HORMONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. JAPAN HUMAN GROWTH HORMONE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 74. JAPAN HUMAN GROWTH HORMONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 75. MALAYSIA HUMAN GROWTH HORMONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 76. MALAYSIA HUMAN GROWTH HORMONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. MALAYSIA HUMAN GROWTH HORMONE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 78. MALAYSIA HUMAN GROWTH HORMONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 79. PHILIPPINES HUMAN GROWTH HORMONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 80. PHILIPPINES HUMAN GROWTH HORMONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. PHILIPPINES HUMAN GROWTH HORMONE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 82. PHILIPPINES HUMAN GROWTH HORMONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 83. SINGAPORE HUMAN GROWTH HORMONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 84. SINGAPORE HUMAN GROWTH HORMONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. SINGAPORE HUMAN GROWTH HORMONE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 86. SINGAPORE HUMAN GROWTH HORMONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH KOREA HUMAN GROWTH HORMONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH KOREA HUMAN GROWTH HORMONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. SOUTH KOREA HUMAN GROWTH HORMONE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 90. SOUTH KOREA HUMAN GROWTH HORMONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 91. TAIWAN HUMAN GROWTH HORMONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 92. TAIWAN HUMAN GROWTH HORMONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. TAIWAN HUMAN GROWTH HORMONE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 94. TAIWAN HUMAN GROWTH HORMONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 95. THAILAND HUMAN GROWTH HORMONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 96. THAILAND HUMAN GROWTH HORMONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. THAILAND HUMAN GROWTH HORMONE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 98. THAILAND HUMAN GROWTH HORMONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 99. VIETNAM HUMAN GROWTH HORMONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 100. VIETNAM HUMAN GROWTH HORMONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. VIETNAM HUMAN GROWTH HORMONE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 102. VIETNAM HUMAN GROWTH HORMONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA HUMAN GROWTH HORMONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA HUMAN GROWTH HORMONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA HUMAN GROWTH HORMONE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 106. EUROPE, MIDDLE EAST & AFRICA HUMAN GROWTH HORMONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 107. EUROPE, MIDDLE EAST & AFRICA HUMAN GROWTH HORMONE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 108. DENMARK HUMAN GROWTH HORMONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 109. DENMARK HUMAN GROWTH HORMONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 110. DENMARK HUMAN GROWTH HORMONE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 111. DENMARK HUMAN GROWTH HORMONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 112. EGYPT HUMAN GROWTH HORMONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 113. EGYPT HUMAN GROWTH HORMONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 114. EGYPT HUMAN GROWTH HORMONE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 115. EGYPT HUMAN GROWTH HORMONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 116. FINLAND HUMAN GROWTH HORMONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 117. FINLAND HUMAN GROWTH HORMONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 118. FINLAND HUMAN GROWTH HORMONE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 119. FINLAND HUMAN GROWTH HORMONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 120. FRANCE HUMAN GROWTH HORMONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 121. FRANCE HUMAN GROWTH HORMONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 122. FRANCE HUMAN GROWTH HORMONE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 123. FRANCE HUMAN GROWTH HORMONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 124. GERMANY HUMAN GROWTH HORMONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 125. GERMANY HUMAN GROWTH HORMONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 126. GERMANY HUMAN GROWTH HORMONE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 127. GERMANY HUMAN GROWTH HORMONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 128. ISRAEL HUMAN GROWTH HORMONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 129. ISRAEL HUMAN GROWTH HORMONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 130. ISRAEL HUMAN GROWTH HORMONE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 131. ISRAEL HUMAN GROWTH HORMONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 132. ITALY HUMAN GROWTH HORMONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 133. ITALY HUMAN GROWTH HORMONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 134. ITALY HUMAN GROWTH HORMONE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 135. ITALY HUMAN GROWTH HORMONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 136. NETHERLANDS HUMAN GROWTH HORMONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 137. NETHERLANDS HUMAN GROWTH HORMONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 138. NETHERLANDS HUMAN GROWTH HORMONE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 139. NETHERLANDS HUMAN GROWTH HORMONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 140. NIGERIA HUMAN GROWTH HORMONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 141. NIGERIA HUMAN GROWTH HORMONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 142. NIGERIA HUMAN GROWTH HORMONE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 143. NIGERIA HUMAN GROWTH HORMONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 144. NORWAY HUMAN GROWTH HORMONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 145. NORWAY HUMAN GROWTH HORMONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 146. NORWAY HUMAN GROWTH HORMONE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 147. NORWAY HUMAN GROWTH HORMONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 148. POLAND HUMAN GROWTH HORMONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 149. POLAND HUMAN GROWTH HORMONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 150. POLAND HUMAN GROWTH HORMONE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 151. POLAND HUMAN GROWTH HORMONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 152. QATAR HUMAN GROWTH HORMONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 153. QATAR HUMAN GROWTH HORMONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 154. QATAR HUMAN GROWTH HORMONE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 155. QATAR HUMAN GROWTH HORMONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 156. RUSSIA HUMAN GROWTH HORMONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 157. RUSSIA HUMAN GROWTH HORMONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 158. RUSSIA HUMAN GROWTH HORMONE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 159. RUSSIA HUMAN GROWTH HORMONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 160. SAUDI ARABIA HUMAN GROWTH HORMONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 161. SAUDI ARABIA HUMAN GROWTH HORMONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 162. SAUDI ARABIA HUMAN GROWTH HORMONE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 163. SAUDI ARABIA HUMAN GROWTH HORMONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 164. SOUTH AFRICA HUMAN GROWTH HORMONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 165. SOUTH AFRICA HUMAN GROWTH HORMONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 166. SOUTH AFRICA HUMAN GROWTH HORMONE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 167. SOUTH AFRICA HUMAN GROWTH HORMONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 168. SPAIN HUMAN GROWTH HORMONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 169. SPAIN HUMAN GROWTH HORMONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 170. SPAIN HUMAN GROWTH HORMONE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 171. SPAIN HUMAN GROWTH HORMONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 172. SWEDEN HUMAN GROWTH HORMONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 173. SWEDEN HUMAN GROWTH HORMONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 174. SWEDEN HUMAN GROWTH HORMONE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 175. SWEDEN HUMAN GROWTH HORMONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 176. SWITZERLAND HUMAN GROWTH HORMONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 177. SWITZERLAND HUMAN GROWTH HORMONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 178. SWITZERLAND HUMAN GROWTH HORMONE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 179. SWITZERLAND HUMAN GROWTH HORMONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 180. TURKEY HUMAN GROWTH HORMONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 181. TURKEY HUMAN GROWTH HORMONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 182. TURKEY HUMAN GROWTH HORMONE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 183. TURKEY HUMAN GROWTH HORMONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 184. UNITED ARAB EMIRATES HUMAN GROWTH HORMONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED ARAB EMIRATES HUMAN GROWTH HORMONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED ARAB EMIRATES HUMAN GROWTH HORMONE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED ARAB EMIRATES HUMAN GROWTH HORMONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED KINGDOM HUMAN GROWTH HORMONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 189. UNITED KINGDOM HUMAN GROWTH HORMONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 190. UNITED KINGDOM HUMAN GROWTH HORMONE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 191. UNITED KINGDOM HUMAN GROWTH HORMONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 192. HUMAN GROWTH HORMONE MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 193. HUMAN GROWTH HORMONE MARKET, FPNV POSITIONING MATRIX, 2023